Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Plos One|December 25, 2013
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemiaLindsay K Ryland, Ushma A Doshi, Sriram S Shanmugavelandy, et al.
Journal of Lipid Research|May 4, 2016
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaSamy A F Morad, Terence E Ryan, P Darrell Neufer, et al.
Blood|September 2, 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell LymphomaIpsita Pal, Anuradha Illendula, Andrea Megan Joyner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemiaAndrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Blood Reviews|April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Journal of Lipid Research|August 1, 2019
Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cellsLi-Pin Kao, Samy A F Morad, Traci S Davis, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypesB Bishal Paudel, Su-Fern Tan, Todd E Fox, et al.
Oncotarget|November 9, 2016
Acid ceramidase is upregulated in AML and represents a novel therapeutic targetSu-Fern Tan, Xin Liu, Todd E Fox, et al.
Pageof 8